{"slideshow_credits": null, "snippet": "The mid-December vote on replacing a majority of Allergan\u2019s board is Valeant\u2019s last best hope for its $51 billion hostile takeover.", "abstract": "The mid-December vote on replacing a majority of Allergan\u2019s board is Valeant\u2019s last best hope for its $51 billion hostile takeover.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://dealbook.nytimes.com/2014/09/17/valeants-last-shot-to-woo-owners-of-botox-maker-allergan/", "lead_paragraph": null, "headline": {"main": "Valeant's Last Shot to Woo Owners of Botox Maker Allergan", "kicker": "DealBook"}, "_id": "5419b18a38f0d80959e6b8b3", "word_count": "385", "multimedia": [{"height": 126, "url": "images/2014/09/18/business/dbpix-botox/dbpix-botox-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/09/18/business/dbpix-botox/dbpix-botox-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 392, "url": "images/2014/09/18/business/dbpix-botox/dbpix-botox-articleLarge.jpg", "legacy": {"xlarge": "images/2014/09/18/business/dbpix-botox/dbpix-botox-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "392"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/09/18/business/dbpix-botox/dbpix-botox-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/09/18/business/dbpix-botox/dbpix-botox-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-09-17T12:04:27Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}